These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 16421371

  • 1. Restoring airway surface liquid in cystic fibrosis.
    Ratjen F.
    N Engl J Med; 2006 Jan 19; 354(3):291-3. PubMed ID: 16421371
    [No Abstract] [Full Text] [Related]

  • 2. Inhaled hypertonic saline as a therapy for cystic fibrosis.
    Elkins MR, Bye PT.
    Curr Opin Pulm Med; 2006 Nov 19; 12(6):445-52. PubMed ID: 17053496
    [Abstract] [Full Text] [Related]

  • 3. Hypertonic saline for cystic fibrosis.
    Zarogiannis S, Hatzoglou C, Gourgoulianis K.
    N Engl J Med; 2006 Apr 27; 354(17):1848-51; author reply 1848-51. PubMed ID: 16642590
    [No Abstract] [Full Text] [Related]

  • 4. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
    Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC.
    N Engl J Med; 2006 Jan 19; 354(3):241-50. PubMed ID: 16421365
    [Abstract] [Full Text] [Related]

  • 5. Hypertonic saline and PEP: is it worth a try?
    O'Malley CA.
    Respir Care; 2011 Jun 19; 56(6):886-7. PubMed ID: 21679498
    [No Abstract] [Full Text] [Related]

  • 6. Hypertonic saline for cystic fibrosis.
    Aziz I, Kastelik JA.
    N Engl J Med; 2006 Apr 27; 354(17):1848-51; author reply 1848-51. PubMed ID: 16641405
    [No Abstract] [Full Text] [Related]

  • 7. [Inhaled therapies for cystic fibrosis].
    Lahzami S, Nicod LP.
    Rev Med Suisse; 2011 Nov 23; 7(318):2285-8. PubMed ID: 22400363
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
    Bilton D, Stanford G.
    Curr Opin Pulm Med; 2014 Nov 23; 20(6):601-6. PubMed ID: 25221855
    [Abstract] [Full Text] [Related]

  • 14. Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis.
    Laube BL, Sharpless G, Carson KA, Kelly A, Mogayzel PJ.
    BMC Pulm Med; 2011 Sep 06; 11():45. PubMed ID: 21896198
    [Abstract] [Full Text] [Related]

  • 15. The facilitating effect of hypertonic saline on resolution of airway inflammation in cystic fibrosis.
    Reeves EP, McElvaney NG.
    Am J Respir Crit Care Med; 2012 Jan 15; 185(2):226-7. PubMed ID: 22351955
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ratjen F, Davis SD, Stanojevic S, Kronmal RA, Hinckley Stukovsky KD, Jorgensen N, Rosenfeld M, SHIP Study Group.
    Lancet Respir Med; 2019 Sep 15; 7(9):802-809. PubMed ID: 31178421
    [Abstract] [Full Text] [Related]

  • 20. Inhaled mannitol for the treatment of cystic fibrosis.
    Hurt K, Bilton D.
    Expert Rev Respir Med; 2012 Feb 15; 6(1):19-26. PubMed ID: 22283575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.